Group One Trading, L.P. Gt Biopharma, Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$1.81 - $56.1 $31,472 - $975,466
-17,388 Reduced 99.34%
116 $0
Q2 2022

Aug 11, 2022
BUY
$1.64 - $3.11 $1,613 - $3,060
984 Added 5.96%
17,504 $52,000
Q1 2022

May 12, 2022
BUY
$2.6 - $3.3 $42,952 - $54,516
16,520 New
16,520 $48,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $81.7M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email